Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 6546832, 8 pages
https://doi.org/10.1155/2018/6546832
Research Article

GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly

Xia Wu,1,2,3 Lu Gao,1,2,3 Xiaopeng Guo,1,2,3 Qiang Wang,1,2,3 Zihao Wang,1,2,3 Wei Lian,1,2,3 Wei Liu,4 Jian Sun,5 and Bing Xing1,2,3

1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2China Pituitary Disease Registry Center, Chinese Pituitary Adenoma Cooperative Group, Beijing 100730, China
3Key Laboratory of Endocrinology of National Health and Family Planning Commission, Beijing 100730, China
4Department of General Surgery, Peking Union Medical College Hospital, Beijing 100730, China
5Department of Pathology, Peking Union Medical College Hospital, Beijing 100730, China

Correspondence should be addressed to Bing Xing; moc.nuyila@liamegnibgnix

Received 2 July 2017; Revised 12 September 2017; Accepted 12 November 2017; Published 15 January 2018

Academic Editor: Thomas J. Fahey

Copyright © 2018 Xia Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Jenkins, “Cancers associated with acromegaly,” Neuroendocrinology, vol. 83, no. 3-4, pp. 218–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Dagdelen, N. Cinar, and T. Erbas, “Increased thyroid cancer risk in acromegaly,” Pituitary, vol. 17, no. 4, pp. 299–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Tirosh and I. Shimon, “Complications of acromegaly: thyroid and colon,” Pituitary, vol. 20, no. 1, pp. 70–75, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Boguszewski and J. Ayuk, “Management of endocrine disease: acromegaly and cancer: an old debate revisited,” European Journal of Endocrinology, vol. 175, no. 4, pp. R147–R156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Guo, L. Gao, S. Zhang et al., “Cardiovascular system changes and related risk factors in acromegaly patients: a case-control study,” International Journal of Endocrinology, vol. 2015, Article ID 573643, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Horvath, S. Majlis, R. Rossi et al., “An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 5, pp. 1748–1751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Vallette, S. Ezzat, C. Chik et al., “Emerging trends in the diagnosis and treatment of acromegaly in Canada,” Clinical Endocrinology, vol. 79, no. 1, pp. 79–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. E. Gullu, O. Celik, N. Gazioglu, and P. Kadioglu, “Thyroid cancer is the most common cancer associated with acromegaly,” Pituitary, vol. 13, no. 3, pp. 242–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Davies and H. G. Welch, “Current thyroid cancer trends in the United States,” JAMA Otolaryngology Head & Neck Surgery, vol. 140, no. 4, pp. 317–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Mian, F. Ceccato, S. Barollo et al., “AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up,” PLoS One, vol. 9, no. 7, article e101560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gasperi, E. Martino, L. Manetti et al., “Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study,” Journal of Endocrinological Investigation, vol. 25, no. 3, pp. 240–245, 2002. View at Publisher · View at Google Scholar
  12. P. Tita, M. R. Ambrosio, C. Scollo et al., “High prevalence of differentiated thyroid carcinoma in acromegaly,” Clinical Endocrinology, vol. 63, no. 2, pp. 161–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Zhao, C. Han, X. Shi et al., “Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis,” PLoS One, vol. 9, no. 10, article e109549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Wolinski, A. Stangierski, E. Gurgul et al., “Thyroid lesions in patients with acromegaly—case-control study and update to the meta-analysis,” Endokrynologia Polska, vol. 68, no. 1, pp. 2–6, 2017. View at Publisher · View at Google Scholar
  15. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Reverter, C. Fajardo, E. Resmini et al., “Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?” PLoS One, vol. 9, no. 8, article e104174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. dos Santos, G. C. Nascimento, A. G. Nascimento et al., “Thyroid cancer in patients with acromegaly: a case-control study,” Pituitary, vol. 16, no. 1, pp. 109–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Miyakawa, M. Saji, T. Tsushima, K. Wakai, and K. Shizume, “Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels,” The Journal of Clinical Endocrinology & Metabolism, vol. 67, no. 5, pp. 973–978, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kurimoto, I. Fukuda, N. Hizuka, and K. Takano, “The prevalence of benign and malignant tumors in patients with acromegaly at a single institute,” Endocrine Journal, vol. 55, no. 1, pp. 67–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Bruchim, Z. Attias, and H. Werner, “Targeting the IGF1 axis in cancer proliferation,” Expert Opinion on Therapeutic Targets, vol. 13, no. 10, pp. 1179–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. S. Gotzsche, A. Flyvbjerg, S. Marshall, K. D. Jorgensen, and J. Weeke, “The influence of growth hormone and thyroxine on iodothyronine deiodinase activity in the liver, kidney and brown adipose tissue in hypophysectomized rats,” European Journal of Endocrinology, vol. 125, no. 2, pp. 219–226, 1991. View at Google Scholar
  22. P. C. Eskildsen, A. Kruse, and C. Kirkegaard, “The pituitary-thyroid axis in acromegaly,” Hormone and Metabolic Research, vol. 20, no. 12, pp. 755–757, 1988. View at Publisher · View at Google Scholar
  23. H. B. Uchoa, G. A. Lima, L. L. Correa et al., “Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 57, no. 9, pp. 685–690, 2013. View at Publisher · View at Google Scholar
  24. M. Xing, “BRAF mutation in thyroid cancer,” Endocrine-Related Cancer, vol. 12, no. 2, pp. 245–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Aydin, C. Aydin, S. Dagdelen, G. G. Tezel, and T. Erbas, “Genetic alterations in differentiated thyroid cancer patients with acromegaly,” Experimental and Clinical Endocrinology & Diabetes, vol. 124, no. 03, pp. 198–202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. H. K. Kim, J. S. Lee, M. H. Park et al., “Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly,” PLoS One, vol. 9, no. 10, article e110241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. I. De Martino, M. Fedele, D. Palmieri et al., “B-RAF mutations are a rare event in pituitary adenomas,” Journal of Endocrinological Investigation, vol. 30, no. 1, pp. RC1–RC3, 2007. View at Publisher · View at Google Scholar
  28. I. Ewing, S. Pedder-Smith, G. Franchi et al., “A mutation and expression analysis of the oncogene BRAF in pituitary adenomas,” Clinical Endocrinology, vol. 66, no. 3, pp. 348–352, 2007. View at Publisher · View at Google Scholar · View at Scopus